Get access to the best calls on Wall Street with StreetInsider.com’s Ratings Insider Elite. Get your Free Trial here.
Metabolix, Inc. (NASDAQ: MBLX) announced today that it is implementing a strategic restructuring under which Yield10 Bioscience will become its core business with a focus on developing disruptive technologies for step-change improvements in crop yield to enhance global food security. As part of the restructuring, Metabolix will eliminate approximately 45 positions in its biopolymer operations and corporate organization, and will pursue the sale of its biopolymers business assets. The immediate reduction in force represents approximately 50% of the Companys current workforce. Once the restructuring is complete, Metabol…
Read the full article at: http://www.streetinsider.com/Corporate News/Metabolix (MBLX) to Implementing Strategic Restructuring Making Yield10 Bioscience its Core Business/11852324.html